
Urinalysis Market Report 2026
Global Outlook – By Test Type (Pregnancy And Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), By Product (Consumables, Instruments), By Application (Urinary Tract Infections (UTIs), Kidney Disease, Liver Disease, Diabetes, Hypertension, Other Applications), By End Users (Diagnostic Laboratories, Hospitals And Clinics, Home Care Settings, Research Laboratories And Institutes) - Market Size, Trends, And Global Forecast 2026-2035
Urinalysis Market Overview
• Urinalysis market size has reached to $3.82 billion in 2025 • Expected to grow to $5.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Rising Prevalence Of Chronic Kidney Disease Fuels Expansion Of The Urinalysis Market • Market Trend: Innovative Advances In Urinalysis Technology • North America was the largest region in 2025.What Is Covered Under Urinalysis Market?
A urinalysis, commonly referred to as a urine test, examines urine's visual, chemical, and microscopic components. It involves examining urine's appearance, concentration, and content. It includes a variety of tests that detect and measure various compounds that pass-through urine using a single sample of urine. The urinalysis is used to identify and manage a variety of illnesses, including diabetes, kidney disease, and urogenital infections. The main test type of urinalysis are pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. Pregnancy and fertility tests refer to a pregnancy test that looks for a specific hormone in blood or urine and determines pregnancy. The pregnancy and fertility tests are HCG, a hormone produced during pregnancy, that can use to determine whether someone is pregnant and assist a couple in making pregnancy plans, regardless of whether they want to get pregnant. The different products used in the process are consumables and instruments, that are applied in urinary tract infections (UTIs), kidney disease, liver disease, diabetes, hypertension, and others. It is used by diagnostic laboratories, hospitals and clinics, home care settings, and research laboratories and institutes.
What Is The Urinalysis Market Size and Share 2026?
The urinalysis market size has grown strongly in recent years. It will grow from $3.82 billion in 2025 to $4.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing prevalence of diabetes and kidney diseases, expansion of clinical diagnostic laboratories, rising demand for routine health screening, increased adoption of laboratory automation, improved availability of consumables.What Is The Urinalysis Market Growth Forecast?
The urinalysis market size is expected to see strong growth in the next few years. It will grow to $5.91 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic testing, rising focus on preventive healthcare, expansion of home healthcare diagnostics, growing integration of ai-based interpretation tools, increasing healthcare spending on diagnostics. Major trends in the forecast period include increasing adoption of automated urinalysis analyzers, rising use of point-of-care testing kits, growing integration of digital result management, expansion of home-based urinalysis testing, enhanced focus on diagnostic accuracy.Global Urinalysis Market Segmentation
1) By Test Type: Pregnancy And Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis 2) By Product: Consumables, Instruments 3) By Application: Urinary Tract Infections (UTIs), Kidney Disease, Liver Disease, Diabetes, Hypertension, Other Applications 4) By End Users: Diagnostic Laboratories, Hospitals And Clinics, Home Care Settings, Research Laboratories And Institutes Subsegments: 1) By Pregnancy And Fertility Tests: Urine Pregnancy Tests, Ovulation Prediction Tests 2) By Biochemical Urinalysis: Dipstick Tests, Reagent Strip Tests, Microalbumin Tests 3) By Sediment Urinalysis: Microscopic Examination, Chemical Analysis Of Sediment, Culture TestsWhat Is The Driver Of The Urinalysis Market?
The growing prevalence of chronic kidney disease is expected to propel the growth of the urinalysis market going forward. Kidney disease refers to a medical condition in which the kidneys become damaged and are unable to filter waste and excess fluids from the blood effectively. The growing prevalence of chronic kidney disease is primarily due to rising rates of diabetes, which can gradually damage the kidneys over time and impair their ability to function properly. Urinalysis helps identify early signs of kidney disease by detecting abnormalities in urine such as protein, blood, or waste imbalances that reflect declining kidney function. For instance, in June 2023, according to the publications by the Oxford University Press, a UK-based department of the University of Oxford, the prevalence of chronic kidney disease (CKD) in the UK is projected to rise by 4%, increasing from 8.27 million to 8.61 million individuals between 2022 and 2032. Therefore, the growing prevalence of chronic kidney disease is driving the growth of the urinalysis industry.Key Players In The Global Urinalysis Market
Major companies operating in the urinalysis market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health Inc., Abbott Laboratories, Danaher Corporation, Beckman Coulter Inc., Sysmex Corporation, ARKRAY Inc., ACON Laboratories Inc., Bio-Rad Laboratories Inc., URIT Medical Electronic Group Co Ltd., 77 Elektronika Kft, Thermo Fisher Scientific Inc., Teco Diagnostics, Mindray Medical International Limited, Quidel Corporation, Becton Dickinson and Company, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Guangzhou Wondfo Biotech Co. Ltd., Chembio Diagnostic Systems IncGlobal Urinalysis Market Trends and Insights
Major companies operating in the urinalysis market are focused on developing innovative products, such as urine particle analyzers, to gain a competitive edge in the market. Urine analyzers are clinical devices that can be utilized for automated urine testing with multiple analyte detection and quantification capabilities. Urine particle analyzers are more accurate and precise than manual microscopy, which helps to standardize urine particle analysis which reduces inter-observer variability. For instance, in April 2023, Sysmex Europe SE, a Germany-based automated in vitro diagnostics provider, launched the UF-1500 Fully Automated Urine Particle Analyzer. It is specially engineered to achieve significant footprint reductions (by about 30%1) while maintaining high levels of performance and usability. It utilizes the same cutting-edge fluorescence flow cytometry technology as our flagship UF-5000. It meets a range of customer needs, including the need for a fully automated urinalysis workstation in developed and emerging markets, as well as the need for backup and satellite systems for extensive facilities that have previously installed the UN-Series, it also supports connectivity to our UC-3500 urine chemistry analyzers.What Are Latest Mergers And Acquisitions In The Urinalysis Market?
In July 2023, LGC Clinical Diagnostics, a UK-based diagnostics and life sciences tools company acquired Kova International Inc. for an undisclosed amount. Through this acquisition, LGC aims to strengthen its clinical quality control and in-vitro diagnostics offerings by integrating Kova’s urinalysis and toxicology quality control products used in clinical laboratories. Kova International, Inc. is a US-based manufacturer of in-vitro urinalysis and toxicology control materials.Regional Outlook
North America was the largest region in the urinalysis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Urinalysis Market?
The urinalysis market consists of revenues earned by entities by providing urinalysis services by providing visual exam of urine, dipstick test, screening tests, reagents test, culture test and microscopic exam of urine. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinalysis market also includes sales of automated urine analyzers, point of care analyzers, integrated urine analyzers, strip reader connect system equipment which are used in providing urinalysis services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Urinalysis Market Report 2026?
The urinalysis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the urinalysis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Urinalysis Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.17 billion |
| Revenue Forecast In 2035 | $5.91 billion |
| Growth Rate | CAGR of 9.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Test Type, Product, Application, End Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Cardinal Health Inc., Abbott Laboratories, Danaher Corporation, Beckman Coulter Inc., Sysmex Corporation, ARKRAY Inc., ACON Laboratories Inc., Bio-Rad Laboratories Inc., URIT Medical Electronic Group Co Ltd., 77 Elektronika Kft, Thermo Fisher Scientific Inc., Teco Diagnostics, Mindray Medical International Limited, Quidel Corporation, Becton Dickinson and Company, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Guangzhou Wondfo Biotech Co. Ltd., Chembio Diagnostic Systems Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
